# Doxorubicin

## Lipo-Dox inj 20mg (自費用)

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | ILIPD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 適應症     | Treatment of AIDS-related Kaposi's sarcoma in patients with low CD4 (< 200 CD4 lymphocytes/mm3) & diseases in mucosa, skin & internal organs. Treatment of metastasis carcinoma of the ovary in patients with disease that is recurrent to both 1st-line platinum- & paclitaxel-based chemotherapy regimens. As monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 用法用量   | [Breast cancer/Ovarian cancer] 50 mg/m2 once every 4 weeks for as long as the disease does not progress and the patient continues to tolerate treatment.[Multiple myeloma] 30 mg/m2 on day 4 of the bortezomib 3 week regimen as a 1 hour infusion administered immediately after the bortezomib infusion. The bortezomib regimen consists of 1.3 mg/m2 on days 1, 4, 8, and 11 every 3 weeks. The dose should be repeated as long as patients respond satisfactorily and tolerate treatment. Day 4 dosing of both medicinal products may be delayed up to 48 hours as medically necessary. Doses of bortezomib should be at least 72 hours apart. [AIDS-related Kaposi sarcoma (AIDS-KS)] 20 mg/m2 once every 2-3 weeks for 2-3 months is recommended to achieve a therapeutic response. Continue treatment as needed to maintain a therapeutic response. Avoid intervals shorter than 10 days. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 禁忌       | Severe hypersensitivity (including anaphylaxis) to doxorubicin liposomal, conventional doxorubicin, or any component of the formulation. Breast-feeding. AIDS-KS patients effectively treat with local or systemic α-interferon                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用     | Infusion-associated acute reactions, stomatitis, Palmar-plantar erythrodysesthesia, cardiac toxicity. Nausea, leukopenia, neutropenia, anemia & thrombocytopenia. Asthenia, alopecia, fever, diarrhea. Resp infections, laboratory abnormalities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 孕期建議   | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 哺乳期建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

## Lipo-Dox inj 20mg (健保用)

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | ILIPD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 適應症     | Treatment of AIDS-related Kaposi's sarcoma in patients with low CD4 (< 200 CD4 lymphocytes/mm3) & diseases in mucosa, skin & internal organs. Treatment of metastasis carcinoma of the ovary in patients with disease that is recurrent to both 1st-line platinum- & paclitaxel-based chemotherapy regimens. As monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 用法用量   | [Breast cancer/Ovarian cancer] 50 mg/m2 once every 4 weeks for as long as the disease does not progress and the patient continues to tolerate treatment.[Multiple myeloma] 30 mg/m2 on day 4 of the bortezomib 3 week regimen as a 1 hour infusion administered immediately after the bortezomib infusion. The bortezomib regimen consists of 1.3 mg/m2 on days 1, 4, 8, and 11 every 3 weeks. The dose should be repeated as long as patients respond satisfactorily and tolerate treatment. Day 4 dosing of both medicinal products may be delayed up to 48 hours as medically necessary. Doses of bortezomib should be at least 72 hours apart. [AIDS-related Kaposi sarcoma (AIDS-KS)] 20 mg/m2 once every 2-3 weeks for 2-3 months is recommended to achieve a therapeutic response. Continue treatment as needed to maintain a therapeutic response. Avoid intervals shorter than 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 禁忌       | Severe hypersensitivity (including anaphylaxis) to doxorubicin liposomal, conventional doxorubicin, or any component of the formulation. Breast-feeding. AIDS-KS patients effectively treat with local or systemic α-interferon                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 副作用     | Infusion-associated acute reactions, stomatitis, Palmar-plantar erythrodysesthesia, cardiac toxicity. Nausea, leukopenia, neutropenia, anemia & thrombocytopenia. Asthenia, alopecia, fever, diarrhea. Resp infections, laboratory abnormalities. Dermatologic: Alopecia, Hand-foot syndrome due to cytotoxic therapy (ovarian cancer, 50.6% AIDS-related Kaposi's sarcoma, 3.4% multiple myeloma, 19% ), Rash (ovarian cancer, 28.5%AIDS-related Kaposi's sarcoma, 1% to 5% multiple myeloma, 22% ) Gastrointestinal: Constipation (multiple myeloma, 31% ), Diarrhea (ovarian cancer, 20.9%AIDS-related Kaposi's sarcoma, 7.8%multiple myeloma, 46% ), Loss of appetite (ovarian cancer, 20.1% AIDS-related Kaposi's sarcoma, 1% to 5%multiple myeloma, 19% ), Nausea (ovarian cancer, 46% AIDS-related Kaposi's sarcoma, 16.9%multiple myeloma, 48% ), Stomatitis (ovarian cancer, 41.4% AIDS-related Kaposi's sarcoma, 6.8%multiple myeloma, 20% ), Vomiting (ovarian cancer, 32.6%AIDS-related Kaposi's sarcoma, 7.8%multiple myeloma, 32%) Hematologic: Decreased platelet count (ovarian cancer, 13% to 24.2%; AIDS-related Kaposi's sarcoma, 60.9%; multiple myeloma, 33%), Hemoglobin low (ovarian cancer, 40.2% to 52.6%; AIDS-related Kaposi's sarcoma, 55.4%; multiple myeloma, 25% ), Neutrophil count abnormal (ovarian cancer, 19% to 35.1%; AIDS-related Kaposi's sarcoma, 48.9%; multiple myeloma, 36%) Neurologic: Asthenia (ovarian cancer, 40.2% AIDS-related Kaposi's sarcoma, 9.9% multiple myeloma, 22% ) Psychiatric: Fatigue (multiple myeloma, 36%; ) Other: Drug fever (ovarian cancer, 21.3%AIDS-related Kaposi's sarcoma, 9.1%multiple myeloma, 31% ) |
| 孕期建議   | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

